Skip to main content

Hart Daniel R's Form 4 filing

Avid Bioservices, Inc. (CDMO) · filed Apr 7, 2023

Accession no.
0001683168-23-002229
Filed
Apr 7, 2023
Trade date
Apr 5, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $23.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hart Daniel RCIK 0001346342Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 5, 2023Common Stock, $0.001 par valueSSaleDisposed−750$19.00−$14,25046,207Direct
Apr 5, 2023Common Stock, $0.001 par valueMOption exerciseAcquired+500$5.66+$2,83046,707Direct
Apr 5, 2023Common Stock, $0.001 par valueSSaleDisposed−500$19.00−$9,50046,207Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 5, 2023Common StockMOption exerciseDisposed−500$0.00$0229,880Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)